世界のオピオイド薬市場予測2019-2028

◆英語タイトル:GLOBAL OPIOIDS DRUGS MARKET FORECAST 2019-2028
◆商品コード:INK20AG037
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年8月
◆ページ数:168
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥262,500見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥315,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥472,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、オピオイド薬の世界市場について調査を行い、調査手法、エグゼクティブサマリー、市場動向、主要分析、製品別(ブプレノルフィン、フェンタニル、ヒドロコドン、モルヒネ、オキシコドン)分析、用途別分析、地域別分析、企業情報などをまとめております。
・調査手法
・エグゼクティブサマリー
・市場動向
・主要分析
・オピオイド薬の世界市場規模:製品別(ブプレノルフィン、フェンタニル、ヒドロコドン、モルヒネ、オキシコドン)
・オピオイド薬の世界市場規模:用途別
・オピオイド薬の世界市場規模:地域別
・企業情報
【レポートの概要】

KEY FINDINGS
The global opioids drugs market is anticipated to grow at a CAGR of 2.48% over the forecast period of 2019-2028. The major factors augmenting the global market growth are the growing number of road accidents and surgical procedures, increasing palliative care for patients going through intense suffering, and growing incidence of chronic pain.

MARKET INSIGHTS
Opioids are majorly used to relieve moderate to severe pain, though they can occasionally be used to treat coughing and diarrhea. The opioid drugs are associated with side effects, a high risk of dependence, and addiction. Opioid addiction, overdose, and abuse, are serious health concerns across the world. Novel opioid formulation to reduce the risk of abuse is driving the market growth. The development of abuse-deterrent formulations (ADF) of opioid medications is likely to decrease abuse, misuse, and addiction to opioid drugs. The ADF is designed in such a way that the drug becomes resistant to physical manipulation.
Opioid misuse is one of the major factors restraining market growth. Opioid misuse includes abuse of prescription pain relievers or the use of heroin. The existing market players are focusing on developing innovative dosage forms, which will increase drug efficiency at a minimum dose.

REGIONAL INSIGHTS
The global opioids drugs market has been segregated into North America, Europe, Asia Pacific, and the Rest of the World to analyze the potential of the respective markets. The region of North America holds the largest market share in terms of revenue in 2019. The high rate of approval and launch of new abuse-deterrent formulation (ADF) of the opioid drug is contributing to market growth in the region.

COMPETITIVE INSIGHTS
The market competition is high in the generic space owing to major companies supplying various opioid drugs. Some of the prominent existing players in the market are Daiichi Sankyo, Inc, Teva Pharmaceutical Industries Ltd, Hikma Pharmaceuticals, Janssen Pharmaceuticals, Inc, Lupin Ltd, Johnson & Johnson, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. INCREASING ROAD ACCIDENTS AND SURGICAL PROCEDURES
3.2.2. ESCALATING PALLIATIVE CARE FOR PATIENTS SUFFERING INTENSELY
3.2.3. USAGE OF ABUSE DETERRENT FORMULATIONS TO RESTRICT THE OPIOID ABUSE
3.2.4. GROWING OCCURRENCE OF CHRONIC PAIN
3.3. KEY RESTRAINTS
3.3.1. MISUSE OF OPIOIDS
3.3.2. STRINGENT REGULATORY FRAMEWORK
3.3.3. OPIOID CRISIS ACROSS THE GLOBE
3.3.4. INCREASING NUMBER OF LAWSUITS CASES AGAINST OPIOIDS MANUFACTURERS
3.3.5. RISING OCCURRENCE OF DEATHS RELATED TO OPIOID OVERDOSE
4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER’S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
4.5. REGULATORY FRAMEWORK
4.6. PIPELINE ANALYSIS
4.7. INDUSTRY EVENTS IN OPIOID DRUGS MARKET
4.8. TECHNOLOGICAL ADVANCEMENT
5. MARKET BY PRODUCT
5.1. BUPRENORPHINE
5.2. FENTANYL
5.3. HYDROCODONE
5.4. MORPHINE
5.5. OXYCODONE
5.6. TRAMADOL
5.7. OTHER PRODUCTS
6. MARKET BY APPLICATION
6.1. PAIN RELIEF
6.1.1. CANCER PAIN
6.1.2. POSTOPERATIVE PAIN MANAGEMENT
6.1.3. LOW BACK PAIN
6.1.4. ORTHOPEDIC
6.1.5. FIBROMYALGIA
6.1.6. NEUROPATHIC
6.2. ANESTHESIA
6.3. COUGH SUPPRESSION
6.4. DIARRHEA SUPPRESSION
6.5. DEADDICTION
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA
7.1.1. UNITED STATES
7.1.2. CANADA
7.2. EUROPE
7.2.1. UNITED KINGDOM
7.2.2. GERMANY
7.2.3. FRANCE
7.2.4. ITALY
7.2.5. RUSSIA
7.2.6. BELGIUM
7.2.7. POLAND
7.2.8. REST OF EUROPE
7.3. ASIA PACIFIC
7.3.1. CHINA
7.3.2. JAPAN
7.3.3. INDIA
7.3.4. SOUTH KOREA
7.3.5. INDONESIA
7.3.6. THAILAND
7.3.7. VIETNAM
7.3.8. AUSTRALIA & NEW ZEALAND
7.3.9. REST OF ASIA PACIFIC
7.4. REST OF WORLD
7.4.1. LATIN AMERICA
7.4.2. MIDDLE EAST AND AFRICA
8. COMPANY PROFILES
8.1. ACURA PHARMACEUTICALS INC
8.2. ALLERGAN PLC
8.3. BIODELIVERY SCIENCES INTERNATIONAL INC
8.4. CIPHER PHARMACEUTICALS INC
8.5. COLLEGIUM PHARMACEUTICAL INC
8.6. DAIICHI SANKYO INC
8.7. EGALET CORP
8.8. HIKMA PHARMACEUTICALS PLC
8.9. INDIVIOR INC
8.10. JANSSEN PHARMACEUTICALS INC
8.11. JOHNSON & JOHNSON
8.12. LANNETT CO. INC
8.13. LUPIN LTD
8.14. MYLAN NV
8.15. PFIZER INC
8.16. PURDUE PHARMA LP
8.17. SANOFI-AVENTIS S.A
8.18. SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUN PHARMA)
8.19. TEVA PHARMACEUTICAL INDUSTRIES LTD

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - OPIOIDS DRUGS
TABLE 2: FDA APPROVED OPIOIDS WITH ADF LABELLING
TABLE 3: NUMBER OF LAWSUITS CASES SETTLED BY OPIOIDS MANUFACTURING COMPANIES AND PHARMACIES, 2015–2027
TABLE 4: LIST OF ER/LA OPIOID BRANDED DRUGS, 2017
TABLE 5: LIST OF ER/LA OPIOID GENERIC DRUGS, 2017
TABLE 6: CDC GUIDELINES ON PRESCRIBING OPIOIDS
TABLE 7: PIPELINE ANALYSIS OF OPIOID DRUGS
TABLE 8: GLOBAL OPIOIDS DRUGS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: GLOBAL OPIOIDS DRUGS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 10: GLOBAL BUPRENORPHINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: GLOBAL BUPRENORPHINE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 12: GLOBAL FENTANYL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 13: GLOBAL FENTANYL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 14: GLOBAL HYDROCODONE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 15: GLOBAL HYDROCODONE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 16: GLOBAL MORPHINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 17: GLOBAL MORPHINE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 18: GLOBAL OXYCODONE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 19: GLOBAL OXYCODONE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 20: GLOBAL TRAMADOL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 21: GLOBAL TRAMADOL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 22: GLOBAL OTHER PRODUCTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 23: GLOBAL OTHER PRODUCTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 24: GLOBAL OPIOIDS DRUGS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 25: GLOBAL OPIOIDS DRUGS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 26: GLOBAL PAIN RELIEF MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 27: GLOBAL PAIN RELIEF MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 28: GLOBAL PAIN RELIEF MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 29: GLOBAL PAIN RELIEF MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 30: GLOBAL CANCER PAIN MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 31: GLOBAL CANCER PAIN MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 32: GLOBAL POSTOPERATIVE PAIN MANAGEMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 33: GLOBAL POSTOPERATIVE PAIN MANAGEMENT MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 34: GLOBAL LOW BACK PAIN MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 35: GLOBAL LOW BACK PAIN MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 36: GLOBAL ORTHOPEDIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 37: GLOBAL ORTHOPEDIC MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 38: GLOBAL FIBROMYALGIA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 39: GLOBAL FIBROMYALGIA MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 40: GLOBAL NEUROPATHIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 41: GLOBAL NEUROPATHIC MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 42: GLOBAL ANESTHESIA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 43: GLOBAL ANESTHESIA MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 44: GLOBAL COUGH SUPPRESSION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 45: GLOBAL COUGH SUPPRESSION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 46: GLOBAL DIARRHEA SUPPRESSION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 47: GLOBAL DIARRHEA SUPPRESSION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 48: GLOBAL DEADDICTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 49: GLOBAL DEADDICTION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 50: GLOBAL OPIOIDS DRUGS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 51: GLOBAL OPIOIDS DRUGS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 52: NORTH AMERICA OPIOIDS DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 53: NORTH AMERICA OPIOIDS DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 54: EUROPE OPIOIDS DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 55: EUROPE OPIOIDS DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 56: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 57: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 58: REST OF WORLD OPIOIDS DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 59: REST OF WORLD OPIOIDS DRUGS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のオピオイド薬市場予測2019-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆